Llwytho...
High Drug Prices Hurt Everyone
Turing Pharmaceuticals raised the price of Daraprim 5,500%, illustrating how the absence of competition in the sale of low-volume, low-price drugs can lead to price gouging. For patented medicines, society allows supracompetitive pricing to incentivize innovation. However, Gilead’s decision to sell...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | ACS Med Chem Lett |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
American Chemical
Society
2016
|
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4904249/ https://ncbi.nlm.nih.gov/pubmed/27326322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.6b00139 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|